These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 36042160
1. Potential New Therapeutic Approaches for Cisplatin-Resistant Testicular Germ Cell Tumors. Lengert AVH, Pereira LDNB, Cabral ERM, Gomes INF, Jesus LM, Gonçalves MFS, Rocha AOD, Tassinari TA, Silva LSD, Laus AC, Vidal DO, Pinto MT, Reis RM, Lopes LF. Front Biosci (Landmark Ed); 2022 Aug 16; 27(8):245. PubMed ID: 36042160 [Abstract] [Full Text] [Related]
2. Cisplatin resistance induced in germ cell tumour cells is due to reduced susceptibility towards cell death but not to altered DNA damage induction or repair. Fenske AE, Glaesener S, Bokemeyer C, Thomale J, Dahm-Daphi J, Honecker F, Dartsch DC. Cancer Lett; 2012 Nov 28; 324(2):171-8. PubMed ID: 22613583 [Abstract] [Full Text] [Related]
4. Cisplatin-induced apoptosis in human malignant testicular germ cell lines depends on MEK/ERK activation. Schweyer S, Soruri A, Meschter O, Heintze A, Zschunke F, Miosge N, Thelen P, Schlott T, Radzun HJ, Fayyazi A. Br J Cancer; 2004 Aug 02; 91(3):589-98. PubMed ID: 15266324 [Abstract] [Full Text] [Related]
5. Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer. Nitzsche B, Gloesenkamp C, Schrader M, Hoffmann B, Zengerling F, Balabanov S, Honecker F, Höpfner M. Br J Cancer; 2012 Nov 20; 107(11):1853-63. PubMed ID: 23169338 [Abstract] [Full Text] [Related]
6. Micro-RNA expression in cisplatin resistant germ cell tumor cell lines. Port M, Glaesener S, Ruf C, Riecke A, Bokemeyer C, Meineke V, Honecker F, Abend M. Mol Cancer; 2011 May 15; 10():52. PubMed ID: 21575166 [Abstract] [Full Text] [Related]
7. Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples. Lobo J, Constâncio V, Leite-Silva P, Guimarães R, Cantante M, Braga I, Maurício J, Looijenga LHJ, Henrique R, Jerónimo C. Clin Epigenetics; 2021 Apr 06; 13(1):70. PubMed ID: 33823933 [Abstract] [Full Text] [Related]
8. Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors. Castillo-Avila W, Piulats JM, Garcia Del Muro X, Vidal A, Condom E, Casanovas O, Mora J, Germà JR, Capellà G, Villanueva A, Viñals F. Clin Cancer Res; 2009 May 15; 15(10):3384-95. PubMed ID: 19417025 [Abstract] [Full Text] [Related]
9. IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance. Selfe J, Goddard NC, McIntyre A, Taylor KR, Renshaw J, Popov SD, Thway K, Summersgill B, Huddart RA, Gilbert DC, Shipley JM. J Pathol; 2018 Feb 15; 244(2):242-253. PubMed ID: 29160922 [Abstract] [Full Text] [Related]
14. The PDGFRβ-AKT pathway contributes to CDDP-acquired resistance in testicular germ cell tumors. Juliachs M, Muñoz C, Moutinho CA, Vidal A, Condom E, Esteller M, Graupera M, Casanovas O, Germà JR, Villanueva A, Viñals F. Clin Cancer Res; 2014 Feb 01; 20(3):658-67. PubMed ID: 24277456 [Abstract] [Full Text] [Related]
15. Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours. Cierna Z, Miskovska V, Roska J, Jurkovicova D, Pulzova LB, Sestakova Z, Hurbanova L, Machalekova K, Chovanec M, Rejlekova K, Svetlovska D, Kalavska K, Kajo K, Babal P, Mardiak J, Ward TA, Mego M, Chovanec M. BMC Cancer; 2020 Jan 06; 20(1):17. PubMed ID: 31906898 [Abstract] [Full Text] [Related]
16. Cisplatin‑resistant germ cell tumor models: An exploration of the epithelial‑mesenchymal transition regulator SLUG. Cardoso IIV, Rosa MN, Moreno DA, Tufi LMB, Ramos LP, Pereira LAB, Silva L, Galvão JMS, Tosi IC, Lengert AVH, Da Cruz MC, Teixeira SA, Reis RM, Lopes LF, Pinto MT. Mol Med Rep; 2024 Dec 06; 30(6):. PubMed ID: 39392037 [Abstract] [Full Text] [Related]
17. Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell Lines. Schmidtova S, Kalavska K, Liskova V, Plava J, Miklikova S, Kucerova L, Matuskova M, Rojikova L, Cierna Z, Rogozea A, Konig H, Albany C, Mego M, Chovanec M. Int J Mol Sci; 2021 Apr 20; 22(8):. PubMed ID: 33923996 [Abstract] [Full Text] [Related]
18. Testis-expressed gene 11 inhibits cisplatin-induced DNA damage and contributes to chemoresistance in testicular germ cell tumor. Kitayama S, Ikeda K, Sato W, Takeshita H, Kawakami S, Inoue S, Horie K. Sci Rep; 2022 Nov 01; 12(1):18423. PubMed ID: 36319719 [Abstract] [Full Text] [Related]
19. Proteomic profiling of cisplatin-resistant and cisplatin-sensitive germ cell tumour cell lines using quantitative mass spectrometry. Fichtner A, Bohnenberger H, Elakad O, Richter A, Lenz C, Oing C, Ströbel P, Kueffer S, Nettersheim D, Bremmer F. World J Urol; 2022 Feb 01; 40(2):373-383. PubMed ID: 35084545 [Abstract] [Full Text] [Related]
20. Role of N-cadherin in proliferation, migration, and invasion of germ cell tumours. Bremmer F, Schallenberg S, Jarry H, Küffer S, Kaulfuss S, Burfeind P, Strauß A, Thelen P, Radzun HJ, Ströbel P, Honecker F, Behnes CL. Oncotarget; 2015 Oct 20; 6(32):33426-37. PubMed ID: 26451610 [Abstract] [Full Text] [Related] Page: [Next] [New Search]